Creative Biolabs Oncolytic Virotherapy

Menu

Skip to content
  • Oncolytic Virus Research
  • Oncolytic Virus News

Monthly Archives: October 2022

25Oct/22

Injection of Synthetic RNA Viruses for Cancer Treatment to Address Limitations of Oncolytic Viruses

October 25, 2022Oncolytic Virus News, Oncolytic Virus ResearchOncolytic Virus, Synthetic RNA Virusbiolabs

Oncolytic viruses (OVs) have emerged as a very attractive cancer treatment modality. OVs target cancer cells without affecting normal cells, causing cancer cell lysis by replicating within cancer cells and, at theRead More…

14Oct/22

Creative Biolabs at the 10th Annual Immuno-Oncology Summit

October 14, 2022Uncategorizedbiolabs

The 10th Annual Immuno-Oncology Summit was held in Boston during October 12-14, 2022. Creative Biolabs, as an exhibitor, successfully showcased at the 10th Annual Immuno-Oncology Summit at booth #9 and has attractedRead More…

Recent Posts

  • Combining Oncolytic Viruses with T-cell Therapy Enhances Cancer Treatment
  • Swine Pseudorabies Virus Attenuated Vaccine Shows Potential for Oncolytic Therapy Against Malignant Tumors
  • Oncolytic Virus Therapy CAN-3110 Shows Promise in Treating Aggressive Brain Cancer Glioblastoma
  • Research Reveals New Mechanism of Oncolytic Virus M1 Enhancing DC Vaccine’s Anti-Tumor Effect
  • Oncolytic Viruses Can Induce A “Cold” Tumor to Heat Up and Improve the Efficiency of Immunotherapy in Treating Cancer

Archives

  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • November 2020

Contact Us

USA – UK

Copyright © Creative Biolabs Oncolytic Virotherapy
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Oncolytic Virus Research
  • Oncolytic Virus News